Arrhythmias & electrophysiology

Development and external validation of the GLORIA-AF Bleeding Weighted Risk Score for patients with atrial fibrillation

Eur J Prev CardiolPublished Prognostic model development and external validation study

Authors' conclusion

The GLORIA-AF Bleeding Score showed modestly higher discrimination than HAS-BLED for 1-year major bleeding prediction while retaining clinical interpretability and usability. External validation in independent European and Asia-Pacific registries further supports its transportability beyond the derivation population.

Study context

Population
Patients with atrial fibrillation (AF) (GLORIA-AF Phase II/III derivation; EORP-AF and APHRS-AF external validation)derivation cohort
Participants
20,250 patients
Comparison
GLORIA-AF Bleeding Weighted Risk Score vs HAS-BLED, unweighted GLORIA-AF score and full multivariable Cox model
Outcome
Major bleeding prediction (discrimination by C-index)
Follow-up
1 year
Methodological detailsprospective, multinational, LASSO-penalized regression with stability selection, external validation in EORP-AF and APHRS-AF registries
  • Prospective
  • Multinational
  • LASSO-penalized regression with stability selection
  • External validation in EORP-AF and APHRS-AF registries

Performance

As reported in the abstract

Major bleeding, discrimination (derivation cohort)
Test or modelC-index
GLORIA-AF Bleeding Weighted Risk Score0.688 (95% CI: 0.660-0.717)
HAS-BLED0.631 (95% CI: 0.604-0.658)
Full multivariable regression0.690 (95%CI: 0.661-0.719)

C-index

GLORIA-AF Bleeding Weighted Risk Score0.688 (95% CI: 0.660-0.717)
HAS-BLED0.631 (95% CI: 0.604-0.658)
Full multivariable regression0.690 (95%CI: 0.661-0.719)
  • GLORIA-AF Bleeding Weighted Risk Score vs HAS-BLED: P < 0.001
  • GLORIA-AF Bleeding Weighted Risk Score vs Full multivariable regression: P = 0.084 — comparable discrimination
Major bleeding during 1-year follow-up
317 (1.6%)
Calibration (O:E ratio)
0.996

Further findings

Discrimination for 1-year major bleeding, external validation (EORP-AF and APHRS-AF)

Derived score C-index in external validation
0.674 (95% CI 0.643-0.705; P < 0.001)
Better discrimination, calibration and clinical benefit than HAS-BLED
  • n = 9,752 external validation patients; 148 (1.5%) major bleeding

Original publication

Development and external validation of the GLORIA-AF Bleeding Weighted Risk Score for patients with atrial fibrillation. Eur J Prev Cardiol. Published 29 August 2026. doi:10.1093/eurjpc/zwag447

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.